Skip to search formSkip to main contentSkip to account menu

eliglustat 84 MG Oral Capsule [Cerdelga]

Known as: Cerdelga 84 MG (as eliglustat tartrate 100 MG) Oral Capsule, Cerdelga 84 MG Oral Capsule 
National Institutes of Health

Related topics

Related topics

11 relations
Indigo CarmineLactose MonohydrateMicaOral Capsule

Broader (1)

eliglustat 84 MG Oral Capsule

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
European Commission Grants Marketing Authorization for Cerdelga® (eliglustat), Genzyme’s Oral Therapy for Gaucher Disease Type 1
  • 2015
  • Corpus ID: 53465856
Paris January 22, 2015 Sanofi and its subsidiary Genzyme announced today that the European Commission (EC) has granted marketing… 
Review
2015
Review
2015
Eliglustat: A Review in Gaucher Disease Type 1
Oral eliglustat (Cerdelga®) is approved in several countries for the long-term treatment of adults with Gaucher disease type 1… 
Review
2014
Review
2014
Eliglustat: First Global Approval
Eliglustat [Cerdelga™ (US, EU)], a small-molecule oral glucosylceramide analogue that inhibits the enzyme glucosylceramide… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)